Assignee
BIOGEN CHESAPEAKE LLC
US·13 granted patents·7 pending applications·39 citations·filing 2013–2022
Top patents by PatentIndex Score
20 records- 0191US10004703B2Treatment of alzheimer's disease using compounds that reduce the activity of non-selective CA++ activated ATP-sensitive cation channels regulated by SUR1 channelsBIOGEN CHESAPEAKE LLC·Filed 2013·Granted Jun 26, 2018·15 cites·11 claims
- 0290US10441556B2Composition containing glibenclamideBIOGEN CHESAPEAKE LLC·Filed 2018·Granted Oct 15, 2019·10 cites·11 claims
- 0387US10869835B2Formulations and methods for lyophilization and lyophilates provided therebyBIOGEN CHESAPEAKE LLC·Filed 2019·Granted Dec 22, 2020·1 cites·23 claims
- 0487US10052280B2Methods of intravenous administration of glyburideBIOGEN CHESAPEAKE LLC·Filed 2017·Granted Aug 21, 2018·3 cites·17 claims
- 0586US10426729B2Formulations and methods for lyophilization and lyophilates provided therebyBIOGEN CHESAPEAKE LLC·Filed 2018·Granted Oct 1, 2019·3 cites·18 claims
- 0684US10117834B2Formulations and methods for lyophilization and lyophilates provided therebyBIOGEN CHESAPEAKE LLC·Filed 2014·Granted Nov 6, 2018·4 cites·17 claims
- 0783US10758503B2Composition containing glibenclamideBIOGEN CHESAPEAKE LLC·Filed 2019·Granted Sep 1, 2020·1 cites·20 claims
- 0877US11951085B2Methods of treating injuries or conditions related to CNS edemaBIOGEN CHESAPEAKE LLC·Filed 2021·Granted Apr 9, 2024·0 cites·20 claims
- 0977US11559481B2Methods of intravenous administration of glyburideBIOGEN CHESAPEAKE LLC·Filed 2020·Granted Jan 24, 2023·0 cites·22 claims
- 1077US10688111B2Liquid formulations of compounds active at sulfonylurea receptorsBIOGEN CHESAPEAKE LLC·Filed 2016·Granted Jun 23, 2020·2 cites·24 claims
- 1174US2021244669A1Formulations and methods for lyophilization and lyophilates provided therebyBIOGEN CHESAPEAKE LLC·Filed 2020·Application pending·0 cites
- 1273US10786445B2Methods of intravenous administration of glyburideBIOGEN CHESAPEAKE LLC·Filed 2019·Granted Sep 29, 2020·0 cites·20 claims
- 1370US2022088039A1Methods of medical treatment with sur1-trpm4 channel inhibitorsBIOGEN CHESAPEAKE LLC·Filed 2021·Application pending·0 cites
- 1468US10391053B2Methods of intravenous administration of glyburideBIOGEN CHESAPEAKE LLC·Filed 2017·Granted Aug 27, 2019·0 cites·6 claims
- 1566US2021113500A1Composition containing glibenclamideBIOGEN CHESAPEAKE LLC·Filed 2020·Application pending·0 cites
- 1662US2022280537A1Low-sorbing glyburide formulation and methodsBIOGEN CHESAPEAKE LLC·Filed 2022·Application pending·0 cites
- 1760US11304963B2Methods of medical treatment with SUR1-TRPM4 channel inhibitorsBIOGEN CHESAPEAKE LLC·Filed 2017·Granted Apr 19, 2022·0 cites·11 claims
- 1856US2018280325A1Methods of treating injuries or conditions related to cns edemaBIOGEN CHESAPEAKE LLC·Filed 2016·Application pending·0 cites
- 1946US2019167611A1Methods of treating or preventing amyloid related imaging abnormalities associated with alzheimer's disease treatmentBIOGEN CHESAPEAKE LLC·Filed 2017·Application pending·0 cites
- 2040US2022226353A1Method for treating subjects suffering from central nervous system contusionsBIOGEN CHESAPEAKE LLC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when BIOGEN CHESAPEAKE LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →